Cargando…

An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts

Despite some success with certain hematological malignancies and in contrast with the strong pro-apoptotic effects measured in vitro, the overall response rate of acute lymphoblastic leukemia (ALL) to histone deacetylase inhibitors (HDACis) is low. With the aim to improve the understanding of how HD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinazza, M, Borga, C, Agnusdei, V, Minuzzo, S, Fossati, G, Paganin, M, Michielotto, B, De Paoli, A, Basso, G, Amadori, A, te Kronnie, G, Indraccolo, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816177/ https://www.ncbi.nlm.nih.gov/pubmed/26764573 http://dx.doi.org/10.1038/cddis.2015.394

Ejemplares similares

Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells
por: Pinazza, Marica, et al.
Publicado: (2018)

Targeting NOTCH1 in combination with antimetabolite drugs prolongs life span in relapsed pediatric and adult T-acute lymphoblastic leukemia xenografts
por: Minuzzo, Sonia, et al.
Publicado: (2023)

Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts
por: Agnusdei, Valentina, et al.
Publicado: (2020)

Histone deacetylase inhibitor givinostat has ameliorative effect in the colitis model
por: Dibekoğlu, Cengiz, et al.
Publicado: (2022)

Givinostat, a type II histone deacetylase inhibitor, induces potent caspase-dependent apoptosis in human lymphoblastic leukemia
por: Li, Ying, et al.
Publicado: (2016)

Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation
por: Huang, He-Ming, et al.
Publicado: (2021)

AKR1C enzymes sustain therapy resistance in paediatric T-ALL
por: Bortolozzi, Roberta, et al.
Publicado: (2018)

The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis
por: Celesia, Adriana, et al.
Publicado: (2022)

Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
por: Franciosa, Giulia, et al.
Publicado: (2021)

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
por: Zangrando, Andrea, et al.
Publicado: (2009)

ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia
por: Germano, Giuseppe, et al.
Publicado: (2017)

Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells
por: Angeletti, Francesca, et al.
Publicado: (2016)

High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia
por: Vendramini, Elena, et al.
Publicado: (2017)

Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation
por: Milan, Marika, et al.
Publicado: (2018)

Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination
por: Hoch, Lucile, et al.
Publicado: (2022)

Involvement of NADPH Oxidase 1 in Liver Kinase B1-Mediated Effects on Tumor Angiogenesis and Growth
por: Zulato, Elisabetta, et al.
Publicado: (2018)

Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study
por: Comi, Giacomo P., et al.
Publicado: (2023)

Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
por: Huang, Ying, et al.
Publicado: (2011)

The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene
por: Licandro, Simonetta Andrea, et al.
Publicado: (2021)

WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia
por: Bordin, Fulvio, et al.
Publicado: (2018)

Reconstruction of gene regulatory modules from RNA silencing of IFN-α modulators: experimental set-up and inference method
por: Grassi, Angela, et al.
Publicado: (2016)

Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics
por: Taiarol, Lorenzo, et al.
Publicado: (2022)

Analysis of Givinostat/ITF2357 Treatment in a Rat Model of Neonatal Hypoxic-Ischemic Brain Damage
por: Pawelec, Paulina, et al.
Publicado: (2022)

Oncogenic BRAF and p53 Interplay in Melanoma Cells and the Effects of the HDAC Inhibitor ITF2357 (Givinostat)
por: Celesia, Adriana, et al.
Publicado: (2023)

SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia
por: García-Cañaveras, Juan C., et al.
Publicado: (2020)

Wnt activation promotes neuronal differentiation of Glioblastoma
por: Rampazzo, E, et al.
Publicado: (2013)

Wnt activation promotes neuronal differentiation of Glioblastoma
por: Rampazzo, E, et al.
Publicado: (2013)

Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis
por: Borga, Chiara, et al.
Publicado: (2018)

mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells
por: Silic-Benussi, Micol, et al.
Publicado: (2022)

Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study
por: Rambaldi, Alessandro, et al.
Publicado: (2020)

Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian Cancer
por: Mazzoldi, Elena Laura, et al.
Publicado: (2020)

Rewiring of Lipid Metabolism and Storage in Ovarian Cancer Cells after Anti-VEGF Therapy
por: Curtarello, Matteo, et al.
Publicado: (2019)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Pluripotent stem cell-induced skeletal muscle progenitor cells with givinostat promote myoangiogenesis and restore dystrophin in injured Duchenne dystrophic muscle
por: Xuan, Wanling, et al.
Publicado: (2021)

Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts
por: Boso, Daniele, et al.
Publicado: (2023)

Evaluation of Xenograft Efficacy in Immediate Prosthesis-based Breast Reconstruction
por: Sobti, Nikhil, et al.
Publicado: (2022)

Evaluation of Xenograft Efficacy in Immediate Prosthesis-based Breast Reconstruction
por: Sobti, Nikhil, et al.
Publicado: (2022)

Inhibition of histone deacetylases by trans-cinnamic acid and its antitumor effect against colon cancer xenografts in athymic mice
por: ZHU, BINGYAN, et al.
Publicado: (2016)

Targeting histone deacetylases for the treatment of disease
por: Lawless, M W, et al.
Publicado: (2009)

Histone Deacetylases Cooperate with NF-κB to Support the Immediate Migratory Response after Zebrafish Pronephros Injury
por: Zhuang, Mingyue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mutjs0ip0bvn5gpko8b3g519kt